Basic information Safety Supplier Related

AHU-377 (heMicalciuM salt)

Basic information Safety Supplier Related

AHU-377 (heMicalciuM salt) Basic information

Product Name:
AHU-377 (heMicalciuM salt)
Synonyms:
  • AHU-377 (heMicalciuM salt)
  • (alphaR,gammaS)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-[1,1'-biphenyl]-4-pentanoic acid 4-ethyl ester calcium salt (2:1)
  • (2S,4R)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1)
  • AHU-377 hemicalcium salt (2:1)
  • Calciumbis(4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl] amino} -4-oxobutanoate)
  • LCZ696(valsartan + sacubitril) impurity 1
  • Ethyl (αR,γS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-[1,1'-biphenyl]-4-pentanoate hemicalcium salt
  • (alphar
CAS:
1369773-39-6
MF:
C48H56CaN2O10
MW:
861.04364
EINECS:
935-847-3
Product Categories:
  • Intermediates
  • LCZ 696
  • Pharmaceutical Intermediates
  • lcz696
  • 1369773-39-6
Mol File:
1369773-39-6.mol
More
Less

AHU-377 (heMicalciuM salt) Chemical Properties

Melting point:
>140°C (dec.)
Density 
1.24g/cm3 at 20℃
vapor pressure 
0.001Pa at 20℃
storage temp. 
-20°C
solubility 
DMSO (Slightly, Heated), Methanol (Slightly)
form 
powder
color 
white to beige
optical activity
-16.3°(C=0.01g/mL,MEOH, 20°C, 589nm)
InChIKey
DDLCKLBRBPYKQS-AGIGYYLVNA-L
LogP
-0.66-2.9 at 20℃ and pH2-7
More
Less

Safety Information

RIDADR 
UN2811 - class 6.1 - PG 3 - EHS - Toxic solids, organic, n.o.s., HI: all
More
Less

AHU-377 (heMicalciuM salt) Usage And Synthesis

Uses

Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.

Biochem/physiol Actions

Sacubitril (AHU377) is a prodrug inhibitor of the membrane metallo-endopeptidase neprilysin. Sacubitril forms half of the heart failure combination drug LCZ696, along with the angiotensin-receptor blocker Valsartan. Sacubitril (AHU377) is cojnverted by esterases into the active inhibitor LBQ657, which prevents neprilysin′s degradation of atrial and brain natriuretic peptide, two blood pressure lowering peptides. The AHU377 valsartan combination drug LCZ696 showed a reduction in the risk of cardiovascular death of 20% compared to the standard ACE inhibitor enalapril, and also a 21% drop in the risk of hospitalization.

in vivo

In humans, Sacubitril (AHU-377)(tmax 0.5-1.1 h) are absorbed quickly. Sacubitril hemicalcium salt is converted rapidly into LBQ657 with its tmax being reached in 1.9-3.5 h. Mean t1/2 values for the biologically active LBQ657 is 9.9-11.1 h[2].In vehicle-treated dogs, ANF increases urinary sodium excretion from 17.3±3.6 to 199.5±18.4 pequivkglmin. This effect is potentiated significantly in animals which receive Sacubitril (AHU-377). Urinary volume is also potentiated in animals which receive an iv administration of Sacubitril (AHU-377)[1].

storage

Store at -20°C

AHU-377 (heMicalciuM salt)Supplier

Changzhou Yuanda Pharmaceutical Chemical Co., Ltd. Gold
Tel
0519-83984084
Email
sales@ydpharm.com
Jiangsu Vcare PharmaTech Co., Ltd. Gold
Tel
025-58741518 13327700685
Email
sales@vcarepharmatech.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Beijing HwrkChemical Technology Co., Ltd
Tel
18515581800 18501085097
Email
sales.bj@hwrkchemical.com
Shanghai Scientia Pharmaceutical Technology Co., Ltd.
Tel
21-21-54301573 13917723525
Email
sales@scientiapharm.com